Check out these featured Drug Topics interviews from July 2024.
The Girls Are Back: One Pharmacist’s Journey to Save His Community Pharmacy
Mayank Amin, PharmD, RPh, MBA, owner and chief patient advocate of Skippack Pharmacy, shares his experiences transforming Skippack Pharmacy into a thriving community hub, learnings from his professional journey, the challenges of independent pharmacy ownership, and the beginning of the Superman Pharmacist.
Overcoming PTSD: Farron Dozier Discusses His Experience in the US Army
Farron Dozier, a retired sergeant first class in the US Army, discussed his experience with PTSD from his start in basic training to finding his passion after retiring. He also discussed the negative labeling that comes with a condition like PTSD and how there is a notable disconnect between veterans and civilians.
NCPA Representative Discusses Role in Influencing PBM Reform
Steve Postal, JD, Director of Policy and Regulatory Affairs at NCPA, discusses major changes in the PBM space regarding state legislation.
How Pharmacies Should Prepare as the DSCSA Stabilization Period Ends
Scott Mooney, vice president of distribution operations at McKesson, shared some insights into the stabilization period during a session at McKesson ideaShare 2024.
Pharmacies Can Improve Front End Sales with Foster & Thrive OTC Products
Peter Koo, PharmD, RPh, vice president and general manager of Pharmacy & Healthcare Solutions at McKesson, discussed the company’s private brand of health and wellness products called Foster & Thrive, which aims to help consumers find whatever items they need.
As Pharmacies Face Financial Distress, RxOwnership Uses Data to Increase Profits
Chris Cella, RPh, vice president of RxOwnership at McKesson, noticed changes in the independent pharmacy industry starting 3 to 5 years ago, when margins started getting slimmer and profitability was getting harder to achieve. At RxOwnership, Cella and his team help pharmacy owners dig into their overall financial health by conducting an analysis to help improve their foundation and get their financials in order.
Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.